{
  "actions": [
    {
      "acted_at": "1997-04-10", 
      "committee": "House Committee on National Security", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on National Security.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1997-04-21", 
      "in_committee": "House Committee on National Security", 
      "references": [], 
      "text": "Executive Comment Requested from DOD.", 
      "type": "action"
    }, 
    {
      "acted_at": "1997-04-21", 
      "in_committee": "House Committee on National Security", 
      "references": [], 
      "subcommittee": "Military Personnel", 
      "text": "Referred to the Subcommittee on Military Personnel.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1997-11-06", 
      "bill_ids": [
        "hr1119-105"
      ], 
      "in_committee": "House Committee on National Security", 
      "references": [], 
      "text": "See H.R.1119.", 
      "type": "action"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1294-105", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House National Security", 
      "committee_id": "HSAS"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House National Security", 
      "committee_id": "HSAS", 
      "subcommittee": "Subcommittee on Military Personnel", 
      "subcommittee_id": "02"
    }
  ], 
  "congress": "105", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1997-04-10", 
  "number": "1294", 
  "official_title": "To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr1119-105", 
      "reason": "related"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "district": "1", 
    "name": "Kennedy, Patrick J.", 
    "state": "RI", 
    "thomas_id": "00627", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1997-04-10", 
  "subjects": [
    "Armed forces and national security", 
    "Clinical trials", 
    "Congress", 
    "Congressional reporting requirements", 
    "Drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Informed consent (Medical law)", 
    "Law", 
    "Military medicine", 
    "Pharmaceutical research", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Armed forces and national security", 
  "summary": {
    "as": "Introduced", 
    "date": "1997-04-10", 
    "text": "Amends provisions governing the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) to provide that, whenever the Secretary of Defense requests or requires a member of the armed forces to receive an investigational new drug, the Secretary shall provide such member a notice identifying such drug as an investigational new drug, giving the reasons why such drug is being administered and disclosing possible side effects. Requires such notice to be provided before such drug is administered, if practicable, but in no case no later than 30 days afterwards. Requires the Secretary to report to the Congress the reasons a form of notice other than written notice is used."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:38:37-05:00"
}